Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000862080 | SCV001002524 | likely benign | Drash syndrome; Frasier syndrome; Wilms tumor 1; 11p partial monosomy syndrome | 2023-10-19 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255550 | SCV002530520 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-23 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002507467 | SCV002809257 | likely benign | Aniridia 1; Drash syndrome; Frasier syndrome; Meacham syndrome; Mesothelioma, malignant; Nephrotic syndrome, type 4; Wilms tumor 1; 11p partial monosomy syndrome | 2022-03-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003389834 | SCV004129977 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | WT1: BP4, BP7 |
Prevention |
RCV004549922 | SCV004791776 | likely benign | WT1-related disorder | 2023-01-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |